Published in Genetika on October 01, 1982
Downregulation of VEGF-C expression in lung and colon cancer cells decelerates tumor growth and inhibits metastasis via multiple mechanisms. Oncogene (2011) 1.26
Chromosome changes caused by alterations of p53 expression. Mutat Res (1996) 1.22
11q deletions in human colorectal carcinomas: cytogenetics and restriction fragment length polymorphism analysis. Genes Chromosomes Cancer (1993) 1.05
Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells. Biochemistry (Mosc) (2008) 1.04
Disruption of actin microfilaments by cytochalasin D leads to activation of p53. FEBS Lett (1998) 1.00
Activation of p53-mediated cell cycle checkpoint in response to micronuclei formation. J Cell Sci (1998) 0.94
P53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints. Oncogene (1999) 0.94
p53 does not control the spindle assembly cell cycle checkpoint but mediates G1 arrest in response to disruption of microtubule system. Cell Biol Int (1999) 0.93
p53 activation in response to microtubule disruption is mediated by integrin-Erk signaling. Oncogene (2001) 0.93
p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1/VEGF-A pathway. Cancer Lett (2008) 0.91
Restoration of p53 tumor-suppressor activity in human tumor cells in vitro and in their xenografts in vivo by recombinant avian adenovirus CELO-p53. Gene Ther (2004) 0.86
Specific karyotypic alterations in colchicine-resistant cells. Cytogenet Cell Genet (1981) 0.86
Cell-specific effects of RAS oncogene and protein kinase C agonist TPA on P-glycoprotein function. FEBS Lett (1995) 0.86
[Effect of on various cell lines of p53 cDNA, expressed under the control of an exogenous homologous promotor]. Mol Biol (Mosk) (1995) 0.86
Karyotype peculiarities of human colorectal adenocarcinomas. Hum Genet (1991) 0.85
[Functional heterogeneity of p53-responsive elements]. Mol Biol (Mosk) (1996) 0.85
Gene amplification in Djungarian hamster cell lines possessing decreased plasma membrane permeability for colchicine and some other drugs. Chromosoma (1985) 0.82
Comparison of mitostatic effect, cell uptake and tubulin-binding activity on colchicine and colcemid. Biochim Biophys Acta (1981) 0.81
Cloning and characterization of DNA sequences amplified in multidrug-resistant Djungarian hamster and mouse cells. Somat Cell Mol Genet (1987) 0.81
Colcemid-induced polyploidy and aneuploidy in normal and tumour cells in vitro. Int J Cancer (1975) 0.80
Regular pattern of karyotypic alterations accompanying gene amplification in Djungarian hamster cells: study of colchicine, adriablastin, and methotrexate resistance. Chromosoma (1985) 0.79
Distinct effects of various p53 mutants on differentiation and viability of human K562 leukemia cells. Oncol Res (1997) 0.79
[The protective role of p53 in Ras-induced transformation of REF52 cells]. Mol Biol (Mosk) (2003) 0.79
[Effect of inactivating the p33ING1 tumor suppressor on the function of cell cycle "checkpoints" and genome stability]. Genetika (2000) 0.78
[Hyperproduction of a specific protein in cells resistant to colchicine and adriablastin]. Biull Eksp Biol Med (1983) 0.77
[The human adenosine deaminase gene contains a p53-responsive element]. Dokl Akad Nauk (1996) 0.77
[Mutation of p53 is necessary for stable transformation of REF52 cells by myc+ras oncogenes]. Mol Biol (Mosk) (2000) 0.76
Decreased sensitivity of multidrug-resistant tumor cells to cisplatin is correlated with sorcin gene co-amplification. Neoplasma (1995) 0.76
[Construction of chimeric tumor suppressor p53 resistant to the dominant-negative interaction with p53 mutants]. Mol Biol (Mosk) (2002) 0.76
[p53 with a mutation in codon 273 increases the probability of amplifying the dhfr gene in Rat-1 and LIM1215 cells]. Genetika (1995) 0.75
[Specific karyotype changes in cells resistant to colchicine]. Genetika (1981) 0.75
[New Djungarian hamster cell lines with selective cytoplasmic and nuclear genetic markers]. Genetika (1982) 0.75
[Effect of some drugs on colchicine uptake by colchicine-sensitive and resistant cells]. Biull Eksp Biol Med (1979) 0.75
[Increased tendency to chromosome nondisjunction arising as a result of Robertsonian translocations]. Genetika (1974) 0.75
[The differentiation of tumor cells of the human large intestine during the acquisition of multiple drug resistance]. Arkh Patol (1994) 0.75
[Specific DNA-binding properties of oncoprotein p53 in human tumor cells]. Dokl Akad Nauk (1993) 0.75
[In vitro induction of numerical changes in the karyotype of normal and transformed Djungarian and Chinese hamster cells]. Genetika (1975) 0.75
[Characteristics of the karyotype changes in Djungarian hamster cells resistant to methotrexate]. Genetika (1983) 0.75
[Progress in understanding moleculr mechanisms of oncogenesis, and novel methods of tumor growth control]. Vestn Ross Akad Med Nauk (2007) 0.75
[Isolation of DNA probes for the detection of sequences amplified in colchicine-resistant cells]. Mol Biol (Mosk) (1986) 0.75
[Stimulation of differentiation of LIM 1215 large intestinal tumor cells during expression of the p53 exogenous antioncogene or the activated ras oncogene]. Arkh Patol (1996) 0.75
[Genome instability and oncogenesis]. Mol Biol (Mosk) (2007) 0.75
[Cloning and characteristics of DNA sequences amplified in Djungarian hamster cells with multidrug resistance]. Mol Gen Mikrobiol Virusol (1987) 0.75
Newly formed chromosome-like structures in independent mouse P388 sublines with developed in vivo mdr1 gene amplification. Somat Cell Mol Genet (1991) 0.75
[Chromosomal and extrachromosomal localization of amplified genes in colchicine-resistant cells]. Dokl Akad Nauk SSSR (1982) 0.75
[Role of the nucleus and the cytoplasm in determining the change in the permeability for colchichine of the plasma membrane of mouse cells]. Genetika (1982) 0.75
[Relation of mammalian cell resistance to actinomycin D with a change in the karyotype and a decrease in cytoplasmic membrane permeability]. Genetika (1981) 0.75
[Genetic analysis of the resistance of mouse somatic cells to colchicine]. Genetika (1978) 0.75
[Effect of inactivating various components of the signal pathways of the tumor suppressor p53 on genomic stability]. Genetika (1999) 0.75
[Amplification of genome regions in the somatic cells of mammals resistant to colchicine. III. Localization of the amplified genes in minute chromatin bodies]. Genetika (1982) 0.75
[Relationship between amplicon composition and cytologic type of structures containing amplified DNA in murine P388 cells with multiple drug resistance]. Genetika (1995) 0.75
Enhanced expression of 1p32 and 1p22 fragile sites in lymphocytes in cutaneous malignant melanomas. Cancer Genet Cytogenet (1992) 0.75
[Mouse cell line with stable inheritance of colchicine resistance]. Biull Eksp Biol Med (1981) 0.75
[Genetic study of the resistance of mouse somatic cells to colchicine (high resistance level)]. Genetika (1979) 0.75
[Opposite effect of p53 on nucleotide metabolizing enzyme activity in Rat1 cells and their sublines, transformed by N-RAS or v-mos oncogenes]. Biokhimiia (1995) 0.75
[Gene amplification in murine leukemia cells with multiple drug resistance acquired in vivo]. Genetika (1987) 0.75
[The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells]. Tsitologiia (1996) 0.75
[Dominant-negative inactivation of p53: the effect of the proportion between trans-dominant inhibitor and its target]. Mol Biol (Mosk) (2003) 0.75
[Segments of Djungarian hamster chromosomes, specific for translocation of integration of amplified mdr1 genes, do not possess increased instability]. Genetika (1991) 0.75
[Amplification of portions of the genome in mammalian somatic cells resistant to colchicine. VI. Restriction analysis of the amplified DNA sequences]. Genetika (1983) 0.75
[Priorities in research of hemoblastosis]. Vestn Ross Akad Med Nauk (1999) 0.75
[Identification of genes activated by mutant forms of p53]. Mol Biol (Mosk) (2000) 0.75
[Oncogenes, antioncogenes and carcinogenesis]. Arkh Patol (1990) 0.75
[Murine near-diploid cell clones: a model for the genetic analysis of signs of transformation]. Vopr Onkol (1980) 0.75
[Induction of gene amplification in Djungarian hamster cells by various chemical carcinogens]. Biull Eksp Biol Med (1986) 0.75
[Effects of various mutant p53 on the sensitivity of cells to cytostatics]. Biull Eksp Biol Med (1999) 0.75
[In vitro induction of numerical changes in the karyotype of normal and transformed cells of Dzhungarian and Chinese hamsters]. Genetika (1975) 0.75
[Changes in the genotype and phenotype determining the resistance of Djungarian hamster somatic cells to adriablastin]. Biull Eksp Biol Med (1983) 0.75
[Pattern of evolution of amplicons during the development of multiple drug resistance in Djungarian hamster cells]. Mol Gen Mikrobiol Virusol (1987) 0.75